Effects of natural products on fructose-induced nonalcoholic fatty liver disease (NAFLD)

Nutrients

Volumn 9, Issue 2, 2017, Pages

  Chen, Qian ^a   Wang, Tingting ^a   Li, Jian ^a   Wang, Sijian ^a   Qiu, Feng ^a   Yu, Haiyang ^a   Zhang, Yi ^a   Wang, Tao ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Fructose induced NAFLD; Inflammatory pathways; Insulin resistance; Lipogenesis; Mitochondrial dysfunction; Natural products

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; CURCUMIN; EPICATECHIN; FATTY ACID SYNTHASE; FRUCTOSE; GLUCOSE TRANSPORTER 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; LIVER X RECEPTOR ALPHA; NATURAL PRODUCT; OXYMATRINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHENOL DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; RESVERATROL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR; VERY LOW DENSITY LIPOPROTEIN; BIOLOGICAL PRODUCT; CATECHIN; STILBENE DERIVATIVE;

ANEMARRHENA ASPHODELOIDES; ANTIINFLAMMATORY ACTIVITY; BLACK CUMIN; CAMELLIA SINENSIS; DYSLIPIDEMIA; FATTY LIVER; GENE EXPRESSION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPOGENESIS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIGNAL TRANSDUCTION; SOPHORA FLAVESCENS; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; MITOCHONDRION; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYSIOLOGY;

ANIMALS; BIOLOGICAL PRODUCTS; CATECHIN; CURCUMIN; FRUCTOSE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPOGENESIS; MITOCHONDRIA; NON-ALCOHOLIC FATTY LIVER DISEASE; STILBENES;

EID: 85011650191     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9020096     Document Type: Review

References (62)

1. Lim, J.S., Mietus-Snyder, M., Valente, A., Schwarz, J.M., Lustig, R.H. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat. Rev. Gastroenterol. Hepatol. 2010, 7, 251-264.
2. Vos, M.B., Lavine, J.E. Dietary fructose in nonalcoholic fatty liver disease. Hepatology 2013, 57, 2525-2531.
3. Bray, G.A., Popkin, B.M. Dietary sugar and body weight: Have we reached a crisis in the epidemic of obesity and diabetes?: Health be damned! Pour on the sugar. Diabetes Care 2014, 37, 950-956.
4. Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J.L., Diehl, A.M., Johnson, R.J., Abdelmalek, M.F. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J. Hepatol. 2008, 48, 993-999.
5. Butler, A.A., St-Onge, M.P., Siebert, E.A., Medici, V., Stanhope, K.L., Havel, P.J. Differential responses of plasma adropin concentrations to dietary glucose or fructose consumption in humans. Sci. Rep. 2015, 5, 14691.
6. Asimakopoulou, A., Weiskirchen, S., Weiskirchen, R. Lipocalin 2 (LCN2) expression in hepatic malfunction and therapy. Front. Physiol. 2016, 7, 430.
7. Alwahsh, S.M., Xu, M., Seyhan, H.A., Ahmad, S., Mihm, S., Ramadori, G., Schultze, F.C. Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver. World J. Gastroenterol. 2014, 20, 1807-1821.
8. Abdelmalek, M.F., Suzuki, A., Guy, C., Unalp-Arida, A., Colvin, R., Johnson, R.J., Diehl, A.M. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 2010, 51, 1961-1971.
9. Johnson, R.J., Segal, M.S., Sautin, Y., Nakagawa, T., Feig, D.I., Kang, D.H., Gersch, M.S., Benner, S., Sánchez-Lozada, L.G. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am. J. Clin. Nutr. 2007, 86, 899-906.
10. Mayes, P.A. Intermediary metabolism of fructose. Am. J. Clin. Nutr. 1993, 58, 754S-765S.
11. DeBosch, B.J., Chen, Z., Saben, J.L., Finck, B.N., Moley, K.H. Glucose transporter 8 (glut8) mediates fructose-induced de novo lipogenesis and macrosteatosis. J. Biol. Chem. 2014, 289, 10989-10998.
12. Johnson, R.J., Perez-Pozo, S.E., Sautin, Y.Y., Manitius, J., Sanchez-Lozada, L.G., Feig, D.I., Shafiu, M., Segal, M., Glassock, R.J., Shimada, M., et al. Hypothesis: Could excessive fructose intake and uric acid cause type 2 diabetes? Endocr. Rev. 2009, 30, 96-116.
13. Basciano, H., Federico, L., Adeli, K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr. Metab. 2005, 2, 5.
14. Sun, S.Z., Empie, M.W. Fructose metabolism in humans-what isotopic tracer studies tell us. Nutr. Metab. 2012, 9, 89.
15. Fan, J.G., Farrell, G.C. Epidemiology of non-alcoholic fatty liver disease in China. J. Hepatol. 2009, 50, 204-210.
16. Tziomalos, K., Athyros, V.G., Paschos, P., Karagiannis, A. Nonalcoholic fatty liver disease and statins. Meta. Clin. Exper. 2015, 64, 1215-1223.
17. Calzadilla Bertot, L., Adams, L.A. The natural course of non-alcoholic fatty liver disease. Int. J. Mol. Sci. 2016, 17, E774.
18. De la Iglesia, R., Loria-Kohen, V., Zulet, M.A., Martinez, J.A., Reglero, G., Ramirez de Molina, A. Dietary strategies implicated in the prevention and treatment of metabolic syndrome. Int. J. Mol. Sci. 2016, 17, E1877.
19. Hsu, W.H., Lee, B.H., Pan, T.M. Leptin-induced mitochondrial fusion mediates hepatic lipid accumulation. Int. J. Obes. 2015, 39, 1750-1756.
20. Alwahsh, S.M., Xu, M., Schultze, F.C., Wilting, J., Mihm, S., Raddatz, D., Ramadori, G. Combination of alcohol and fructose exacerbates metabolic imbalance in terms of hepatic damage, dyslipidemia, and insulin resistance in rats. PLoS ONE 2014, 9, e104220.
21. Rutledge, A.C., Adeli, K. Fructose and the metabolic syndrome: Pathophysiology and molecular mechanisms. Nutr. Rev. 2007, 65, 13-23.
22. Dekker, M.J., Su, Q., Baker, C., Rutledge, A.C., Adeli, K. Fructose: A highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am. J. Physiol. Endocr. Metab. 2010, 299, E685-E694.
23. Pan, H., Guo, J., Su, Z. Advances in understanding the interrelations between leptin resistance and obesity. Physiol. Behav. 2014, 130, 157-169.
24. Alwahsh, S.M., Gebhardt, R. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD). Arch. Toxicol. 2016, doi:10.1007/s00204-016-1892-7.
25. Antu, K.A., Riya, M.P., Nair, A., Mishra, A., Srivastava, A.K., Raghu, K.G. Symplocos cochinchinensis enhances insulin sensitivity via the down regulation of lipogenesis and insulin resistance in high energy diet rat model. J. Ethnopharmacol. 2016, 193, 500-509.
26. Liu, L., Yang, M., Lin, X., Li, Y., Liu, C., Yang, Y., Yamahara, J., Wang, J., Li, Y. Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats. J. Ethnopharmacol. 2013, 150, 1045-1052.
27. Shrestha, S., Ehlers, S.J., Lee, J.Y., Fernandez, M.L., Koo, S.I. Dietary green tea extract lowers plasma and hepatic triglycerides and decreases the expression of sterol regulatory element-binding protein-1c mRNA and its responsive genes in fructose-fed, ovariectomized rats. J. Nutr. 2009, 139, 640-645.
28. Prakash, P., Singh, V., Jain, M., Rana, M., Khanna, V., Barthwal, M.K., Dikshit, M. Silymarin ameliorates fructose induced insulin resistance syndrome by reducing de novo hepatic lipogenesis in the rat. Eur. J. Pharmacol. 2014, 727, 15-28.
29. Maithilikarpagaselvi, N., Sridhar, M.G., Swaminathan, R.P., Sripradha, R., Badhe, B. Curcumin inhibits hyperlipidemia and hepatic fat accumulation in high-fructose-fed male Wistar rats. Pharm. Biol. 2016, 54, 2857-2863.
30. Liu, C., Li, Y., Zuo, G., Xu, W., Gao, H., Yang, Y., Yamahara, J., Wang, J., Li, Y. Oleanolic acid diminishes liquid fructose-induced fatty liver in rats: Role of modulation of hepatic sterol regulatory element-binding protein-1c-mediated expression of genes responsible for de novo fatty acid synthesis. Evid. Based Compl. Alt. 2013, 2013, 534084.
31. Xing, X., Li, D., Chen, D., Zhou, L., Chonan, R., Yamahara, J., Wang, J., Li, Y. Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A: Diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats: A link to amelioration of fatty liver. Toxicol. Appl. Pharmacol. 2014, 280, 207-215.
32. Li, W., Li, Z., Han, X., Huang, D., Lu, Y., Yang, X. Enhancing the hepatic protective effect of genistein by oral administration with stachyose in mice with chronic high fructose diet consumption. Food Funct. 2016, 7, 2420-2430.
33. Yamazaki, T., Kishimoto, K., Miura, S., Ezaki, O. Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 protein. J. Nutr. Biochem. 2012, 23, 123-132.
34. Ajiboye, T.O., Hussaini, A.A., Nafiu, B.Y., Ibitoye, O.B. Aqueous seed extract of Hunteria umbellata (K. Schum.) Hallier f. (Apocynaceae) palliates hyperglycemia, insulin resistance, dyslipidemia, inflammation and oxidative stress in high-fructose diet-induced metabolic syndrome in rats. J. Ethnopharmacol. 2016, doi:10.1016/j.jep.2016.
35. Han, X., Li, W., Huang, D., Yang, X. Polyphenols from hawthorn peels and fleshes differently mitigate dyslipidemia, inflammation and oxidative stress in association with modulation of liver injury in high fructose diet-fed mice. Chem. Biol. Interact. 2016, 257, 132-140.
36. Li, R.W., Douglas, T.D., Maiyoh, G.K., Adeli, K., Theriault, A.G. Green tea leaf extract improves lipid and glucose homeostasis in a fructose-fed insulin-resistant hamster model. J. Ethnopharmacol. 2006, 104, 24-31.
37. Shi, L.J., Shi, L., Song, G.Y., Zhang, H.F., Hu, Z.J., Wang, C., Zhang, D.H. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor α (PPARα). Eur. J. Pharmacol. 2013, 714, 89-95.
38. Ge, C.X., Yu, R., Xu, M.X., Li, P.Q., Fan, C.Y., Li, J.M., Kong, L.D. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating er stress in rats. Eur. J. Pharmacol. 2016, 770, 154-164.
39. Prabhakar, P., Reeta, K.H., Maulik, S.K., Dinda, A.K., Gupta, Y.K. Protective effect of thymoquinone against high-fructose diet-induced metabolic syndrome in rats. Eur. J. Nutr. 2015, 54, 1117-1127.
40. Yogalakshmi, B., Sreeja, S., Geetha, R., Radika, M.K., Anuradha, C.V. Grape seed proanthocyanidin rescues rats from steatosis: A comparative and combination study with metformin. J. Llipids 2013, 2013, 153897.
41. Kelany, M.E., Hakami, T.M., Omar, A.H. Curcumin improves the metabolic syndrome in high-fructose-diet-fed rats role of TNF-α, NF-κB, and oxidative stress. Can. J. Physiol. Pharmacol. 2016, 17, 1-11.
42. De Castro, G.S., Cardoso, J.F., Calder, P.C., Jordao, A.A., Vannucchi, H. Fish oil decreases hepatic lipogenic genes in rats fasted and refed on a high fructose diet. Nutrients 2015, 7, 1644-1656.
43. Rodriguez Lanzi, C., Perdicaro, D.J., Antoniolli, A., Fontana, A.R., Miatello, R.M., Bottini, R., Vazquez Prieto, M.A. Grape pomace and grape pomace extract improve insulin signaling in high-fat-fructose fed rat-induced metabolic syndrome. Food Funct. 2016, 7, 1544-1553.
44. Noshahr, Z.S., Shahraki, M.R., Ahmadvand, H., Nourabadi, D., Nakhaei, A. Protective effects of Withania somnifera root on inflammatory markers and insulin resistance in fructose-fed rats. Rep. Biochem. Mol. Biol. 2015, 3, 62-67.
45. Yuan, L., Han, X., Li, W., Ren, D., Yang, X. Isoorientin prevents hyperlipidemia and liver injury by regulating lipid metabolism, antioxidant capability, and inflammatory cytokine release in high-fructose-fed mice. J. Agric. Food Chem. 2016, 64, 2682-2689.
46. Maithilikarpagaselvi, N., Sridhar, M.G., Swaminathan, R.P., Zachariah, B. Curcumin prevents inflammatory response, oxidative stress and insulin resistance in high fructose fed male wistar rats: Potential role of serine kinases. Chem. Biol. Interact. 2016, 244, 187-194.
47. Bettaieb, A., Vazquez Prieto, M.A., Rodriguez Lanzi, C., Miatello, R.M., Haj, F.G., Fraga, C.G., Oteiza, P.I. (−)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress. Free Radic. Biol. Med. 2014, 72, 247-256.
48. Ibrahim, S.M., El-Denshary, E.S., Abdallah, D.M. Geraniol, alone and in combination with pioglitazone, ameliorates fructose-induced metabolic syndrome in rats via the modulation of both inflammatory and oxidative stress status. PLoS ONE 2015, 10, e0117516.
49. Bhuvaneswari, S., Yogalakshmi, B., Sreeja, S., Anuradha, C.V. Astaxanthin reduces hepatic endoplasmic reticulum stress and nuclear factor-kappab-mediated inflammation in high fructose and high fat diet-fed mice. Cell Stress Chaperon. 2014, 19, 183-191.
50. Bao, L., Hu, L., Zhang, Y., Wang, Y.I. Hypolipidemic effects of flavonoids extracted from lomatogonium rotatum. Exp. Ther. Med. 2016, 11, 1417-1424.
51. Ren, D., Zhao, Y., Nie, Y., Lu, X., Sun, Y., Yang, X. Chemical composition of Pleurotus eryngii polysaccharides and their inhibitory effects on high-fructose diet-induced insulin resistance and oxidative stress in mice. Food Funct. 2014, 5, 2609-2620.
52. Lee, Y.K., Kim, J.E., Nam, S.H., Goo, J.S., Choi, S.I., Choi, Y.H., Bae, C.J., Woo, J.M., Cho, J.S., Hwang, D.Y. Differential regulation of the biosynthesis of glucose transporters by the PI3-K and MAPK pathways of insulin signaling by treatment with novel compounds from liriope platyphylla. Int. J. Mol. Med. 2011, 27, 319-327.
53. Narasimhan, A., Chinnaiyan, M., Karundevi, B. Ferulic acid regulates hepatic Glut2 gene expression in high fat and fructose-induced type-2 diabetic adult male rat. Eur. J. Pharmacol. 2015, 761, 391-397.
54. Sadi, G., Ergin, V., Yilmaz, G., Pektas, M.B., Yildirim, O.G., Menevse, A., Akar, F. High-fructose corn syrup-induced hepatic dysfunction in rats: Improving effect of resveratrol. Eur. J. Nutr. 2015, 54, 895-904.
55. Pektas, M.B., Koca, H.B., Sadi, G., Akar, F. Dietary fructose activates insulin signaling and inflammation in adipose tissue: Modulatory role of resveratrol. Biomed. Res. Int. 2016, 2016, 8014252.
56. Arunkumar, E., Karthik, D., Anuradha, C.V. Genistein sensitizes hepatic insulin signaling and modulates lipid regulatory genes through p70 ribosomal S6 kinase-1 inhibition in high-fat-high-fructose diet-fed mice. Pharm. Biol. 2013, 51, 815-824.
57. Bhuvaneswari, S., Anuradha, C.V. Astaxanthin prevents loss of insulin signaling and improves glucose metabolism in liver of insulin resistant mice. Can. J. Physiol. Pharmacol. 2012, 90, 1544-1552.
58. Alwahsh, S.M., Ramadori, G. How does bariatric surgery improve type II diabetes? The neglected importance of the liver in clearing glucose and insulin from the portal blood. J. Obes. Weight Loss Ther. 2015, 5, 1000280.
59. Gupta, A., Miegueu, P., Lapointe, M., Poirier, P., Martin, J., Bastien, M., Tiwari, S., Cianflone, K. Acute post-bariatric surgery increase in orexin levels associates with preferential lipid profile improvement. PLoS ONE 2014, 9, e84803.
60. Dib, N., Kiciak, A., Pietrzak, P., Ferenc, K., Jaworski, P., Kapica, M., Tarnowski, W., Zabielski, R. Early-effect of bariatric surgery (scopinaro method) on intestinal hormones and adipokines in insulin resistant wistar rat. J. Physiol. Pharmacol. 2013, 64, 571-577.
61. Barrière, G., Tartary, M., Rigaud, M. Metformin: A rising star to fight the epithelial mesenchymal transition in oncology. Anticancer Agents Med. Chem. 2013, 13, 333-340.
62. Nair, S., Diehl, A.M., Wiseman, M., Farr, G.H., Jr., Perrillo, R.P. Metformin in the treatment of non-alcoholic steatohepatitis: A pilot open label trial. Aliment. Pharmacol. Ther. 2004, 20, 23-28.